Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical"
Business
Ask the average Israeli where he or she has visited in the United States, and you’ll likely get New York, Los Angeles, or Washington,...
Bio-Tech
Galmed Pharmaceuticals in Israel is developing a medication to treat NASH, a severe form of fatty liver disease affecting 10 percent of the Western...
Business
The FTC has been investigating Valeant for potentially cornering a portion of the lens market.
Mergers & Acquisitions
Generic drug maker Mylan $26bn hostile bid for peer Perrigo looked unlikely to succeed, a few hours before it was set to expire, a...
Business
Gamida Cell develops cellular and immune therapies for the treatment of cancer and orphan genetic diseases.
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"
StartUps
The Technion received approval for 65 patents in the U.S. in 2014, the most of any Israeli university.
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Business
Perrigo Company (NYSE:PRGO; TASE:PRGO) CEO Joseph Papa is ready to talk with Mylan N.V. (MYL) about its takeover bid, but at a higher price....